ALLISON VAUGHAN: Open Payments
NPI 1326618984 · ATLANTIC HIGHLANDS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 87 payments from 17 companies in 2025. Trend: 2023 $2,871 · 2024 $1,758 · 2025 $1,810
Food & beverage: $1,711Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 19 | $470 |
| ABBVIE INC. | 15 | $206 |
| Novartis Pharmaceuticals Corporation | 8 | $179 |
| Lilly USA, LLC | 3 | $161 |
| Janssen Biotech, Inc. | 4 | $149 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $122 |
| Regeneron Healthcare Solutions, Inc. | 6 | $105 |
| Galderma Laboratories, L.P. | 5 | $83 |
| Arcutis Biotherapeutics, Inc. | 5 | $78 |
| UCB, Inc. | 4 | $69 |
Products named: OPZELURA, TREMFYA, EBGLYSS, SKYRIZI, Rhapsido, DUPIXENT, Cabtreo, AKLIEF.
Industry payments across NJ — which companies pay providers there.
